Aljorani, R. H. (2025). Ripasudil, a Rho Kinase Inhibitor, Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation, Oxidative Stress and Rho Kinase Pathways. Zenodo.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Aljorani, Randa Hisham. Ripasudil, a Rho Kinase Inhibitor, Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation, Oxidative Stress and Rho Kinase Pathways. Zenodo, 2025.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Aljorani, Randa Hisham. Ripasudil, a Rho Kinase Inhibitor, Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation, Oxidative Stress and Rho Kinase Pathways. Zenodo, 2025.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.